• Feature: Kidney stones and bone loss
• Case Study: Osteoporosis in children with glucocorticoid-treated illnesses
• Q & A: Is bicycling bad for bones? Fracture and survival odds in the elderly

   

• Feature: Depression and bone loss: What is the connection?
• Case Study: Osteoporosis in children with glucocorticoid-treated illnesses
• Perspective: OC-CIHR New Investigator Award; Eli Lilly Canada Chair in Osteoporosis; Resources for patients

   

• Feature: Focus on long-term care
• Special Feature: Bone health recommendations for women using Depo-Provera®
• Perspective: Report card on access to BMD testing and medications

   

• Feature: Fall prevention: A crucial step in reducing osteoporotic fractures
• Q & A: Genome studies and best indicators for appropriate BMD testing

   

• Feature: CAM: what are osteoporosis patients using?  Good communications is key to keeping patients healthy
• Case Study: Rheumatoid arthritis and osteoporosis: what is the connection?
• Q & A:AON and bisphosphonates; calcium intake

   

• Feature: Vertebral fracture diagnosis: Recommendations to help reduce future risk
• Provincial fomularies focus: Osteoporosis drug coverage in Canada
• Q & A:bisphosphonate treatments and effects on the kidney; teriparatide therapy

   

• Feature: Cancer therapies and osteoporosis: physicians and patients should be aware of the link
• Case Study: Bone health in a 24-year-old cystic fibrosis patient
• Q & A:Acid-suppressing medications and fractures;
  Body weight and BMD

   

• Feature: After fragiligy fracture: strategies for inpatient rehabilitation & osteoporosis follow-up
• Case Study: Assessment of bone risk on COPD patients
• Q & A: Calcium/vitamin D and stress fractures; The link between diabetes and BMD

• Feature:  Males at risk 
• Case Study : After prostate cancer, do patients on ADT need bisphosphonates?
• Q & A: Putting jaw problems in perspective; new once-a-year therapy on the horizon 

Spring/Summer 2005 vol.9 no.2
TOC Summary

• Feature: Height measurement
  Precision is key
• Q&A:  Vitamin K, exercise
  and strontium ranelate
• Perspective: Ontario’s osteoporosis strategy

Winter 2005 vol.9 no.1
TOC Summary

• Feature:  Physical examination pointers - Practical tools for uncovering vertebral compression fractures
• Q&A:  Progesterone and bone health 
• Perspective: NASA technology launches U of T osteoporosis investigation

Fall 2004 vol. 8 no. 3
TOC Summary

• Feature: Before and after - New PTH therapy stimulates bone formation 
• Case: The breast cancer/bone  connection
• Q&A:  A role for geometric measurements in densitometry? 
• Perspective: Joint winners of 2004 Lindy Fraser Award

Spring 2004 vol. 8 no. 2
TOC Summary

• Feature: Seniors at risk - Strategies to prevent falls & fractures
• Case: The Crohn’s connection
• Q&A: Bisphosphonate effect on eyes; Comparing calcium citrate & carbonate
• Perspective: Kudos to Dr. Tenenhouse for outstanding research

Winter 2004 vol. 8 no. 1
TOC Summary

• Feature: The impact of pain - An overview of management techniques
• Case: Transient osteoporosis presents diagnostic challenge
• Q&A: Update on statin therapye
• Perspective: From prevention to rehabilitation: the physiotherapist’s role

Fall 2003 vol. 7 no. 4
TOC Summary

• Feature: Quality control - International densitometry standards improve diagnostic outcome
• Case: Management strategies for osteopenia
• Q&A: New technology for detecting fracture
• Perspective: What can dietitians do for your osteoporosis patients?

Summer 2003 vol. 7 no. 3
TOC Summary

• Feature: From fracture to osteoporosis - Bridging the gap in treatment
• Case: Strategies for preventing bone loss in anorexia nervosa
• Q&A: Is there a link between stroke and BMD?
• Perspective: A message about the importance of recognizing vertebral fractures

Spring 2003 vol. 7 no. 2
TOC Summary

• Feature: SERMs update
• Case: Investigations for osteomalacia in a menopausal patient
• Q&A:A new bisphosphonate on the horizon, bone risks with inhaled glucocorticoids
• Profile: The pharmacist’s point of view

Special Edition
Winter 2003 vol. 7 no. 1
TOC Summary

• Feature: Canada and the OSC lead the way
• Risk Factors: Is my patient at risk?
• Diagnosis The latest in diagnosis
• Pharmacologic Treatment Pharmacologic interventions
• Alternative Therapies Therapeutic alternatives for osteoporosis
• Nonpharmacologic Intervent Nutrition and physical activity: steps to prevention